Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2018 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2018 Volume 18 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice

  • Authors:
    • Qi Yu
    • Fang Wang
    • Xiaodong Meng
    • Yiren Gong
    • Yanli Wang
    • Cangbao Xu
    • Siwang Wang
  • View Affiliations / Copyright

    Affiliations: Institute of Material Medical, School of Pharmacy, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases and Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, Shaanxi 710021, P.R. China
    Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2780-2788
    |
    Published online on: July 3, 2018
       https://doi.org/10.3892/mmr.2018.9239
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Low‑density lipoprotein receptors (LDLRs) may serve a role in the diabetogenic effect of statins; however, the effects of statins on LDLR expression and its regulation in the pancreas and islets have yet to be determined. To exclude the long‑term effects of treatment with atorvastatin, which allows mice to adapt, male C57BL/j and apolipoprotein E‑deficient mice were acutely treated with oral atorvastatin for 6 weeks, and glucose homeostasis and LDLR expression in the pancreas and islets were examined. In the present study, it was observed that the short‑term use of atorvastatin affected insulin sensitivity in normal mice and glucose tolerance in hyperlipidemic mice. Furthermore, it was identified that 6 weeks of treatment with atorvastatin suppressed LDLR expression in the pancreas and pancreatic islets in C57BL/j mice, and an increase in proprotein convertase subtilisin/kexin type 9 expression was additionally observed in the pancreas. However, 6 weeks of treatment with atorvastatin did not affect LDLR expression in the pancreas of hyperlipidemic mice. It may be concluded that the short‑term use of atorvastatin disturbs glucose homeostasis and suppresses LDLR expression in the pancreas and pancreatic islets in C57BL/j mice, suggesting that the role of LDLR in the diabetogenic effect of statins requires further investigation.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Brault M, Ray J, Gomez YH, Mantzoros CS and Daskalopoulou SS: Statin treatment and new-onset diabetes: A review of proposed mechanisms. Metabolism. 63:735–745. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Yu Q, Chen Y and Xu CB: Statins and new-onset diabetes mellitus: LDL receptor may provide a key link. Front Pharmacol. 8:3722017. View Article : Google Scholar : PubMed/NCBI

3 

Besseling J, Kastelein JJ, Defesche JC, Hutten BA and Hovingh GK: Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA. 313:1029–1036. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Yu Q, Su X and Liu E: Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study. Int J Cardiol. 202:954–955. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Ishikawa M, Iwasaki Y, Yatoh S, Kato T, Kumadaki S, Inoue N, Yamamoto T, Matsuzaka T, Nakagawa Y, Yahagi N, et al: Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: A new model for lipotoxicity. J Lipid Res. 49:2524–2534. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Brunham LR, Kruit JK, Verchere CB and Hayden MR: Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest. 118:403–408. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Cheng D, Wang Y, Gao S, Wang X, Sun W, Bai L, Cheng G, Chu Y, Zhao S and Liu E: Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits. Biomed Pharmacother. 72:24–29. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Capel F, Chabrier G, Pitois E, Rigaudière JP, Le Plenier S, Durand C, Jouve C, de Bandt JP, Cynober L and Moinard C: Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity. Br J Pharmacol. 172:4996–5008. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Liang J, Yin K, Cao X, Han Z, Huang Q, Zhang L, Ma W, Ding F, Bi C, Feng D, et al: Attenuation of low ambient temperature-induced myocardial hypertrophy by atorvastatin via promoting Bcl-2 expression. Cell Physiol Biochem. 41:286–295. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Ren XM, Zuo GF, Wu W, Luo J, Ye P, Chen SL and Hu ZY: Atorvastatin alleviates experimental diabetic cardiomyopathy by regulating the GSK-3β-PP2Ac-NF-κB signaling axis. PLoS One. 11:e01667402016. View Article : Google Scholar : PubMed/NCBI

11 

Wu W, Zhao L, Yang P, Zhou W, Li B, Moorhead JF, Varghese Z, Ruan XZ and Chen Y: Inflammatory stress sensitizes the liver to atorvastatin-induced injury in ApoE−/−mice. PLoS One. 11:e01595122016. View Article : Google Scholar : PubMed/NCBI

12 

Lee S, Lee Y, Kim J, An J and Kim K, Lee H, Kong H, Song Y and Kim K: Atorvastatin and rosuvastatin improve physiological parameters and alleviate immune dysfunction in metabolic disorders. Biochem Biophys Res Commun. 478:1242–1247. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Roth L, Rombouts M, Schrijvers DM, Martinet W and De Meyer GR: Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture. Vascul Pharmacol. 80:50–58. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Han H, Chen Y, Zhu J, Ni J, Sun J and Zhang R: Atorvastatin attenuates p-cresyl sulfate-induced atherogenesis and plaque instability in ApoE knockout mice. Mol Med Rep. 14:3122–3128. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Bruder-Nascimento T, Callera GE, Montezano AC, He Y, Antunes TT, Cat Nguyen Dinh A, Tostes RC and Touyz RM: Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: Role of Rac1/2-sensitive Nox-dependent pathways. Clin Sci (Lond). 128:411–423. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Park SH, Sung YY, Nho KJ and Kim HK: Protective activity ethanol extract of the fruits of Illicium verum against atherogenesis in apolipoprotein E knockout mice. BMC Complement Altern Med. 15:2322015. View Article : Google Scholar : PubMed/NCBI

17 

van den Hoek AM, van der Hoorn JW, Maas AC, van den Hoogen RM, van Nieuwkoop A, Droog S, Offerman EH, Pieterman EJ, Havekes LM and Princen HM: APOE*3Leiden. CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome. Diabetes Obes Metab. 16:537–544. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Yu Q, Liu Z, Waqar AB, Ning B, Yang X, Shiomi M, Graham MJ, Crooke RM, Liu E, Dong S and Fan J: Effects of antisense oligonucleotides against C-reactive protein on the development of atherosclerosis in WHHL rabbits. Mediators Inflamm. 2014:9791322014. View Article : Google Scholar : PubMed/NCBI

19 

Yu Q, Wang Y, Yu Y, Li Y, Zhao S, Chen Y, Waqar AB, Fan J and Liu E: Expression of TRPV1 in rabbits and consuming hot pepper affects its body weight. Mol Biol Rep. 39:7583–7589. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Li DS, Yuan YH, Tu HJ, Liang QL and Dai LJ: A protocol for islet isolation from mouse pancreas. Nat Protoc. 4:1649–1652. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Zhao W and Zhao SP: Different effects of statins on induction of diabetes mellitus: An experimental study. Drug Des Devel Ther. 9:6211–6223. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Jensen EC: Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec (Hoboken). 296:378–381. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Ansar S, Koska J and Reaven PD: Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins. Cardiovasc Diabetol. 10:612011. View Article : Google Scholar : PubMed/NCBI

25 

Bot I, Jukema JW, Lankhuizen IM, van Berkel TJ and Biessen EA: Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. Atherosclerosis. 214:295–300. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Du XM, Kim MJ, Hou L, Le Goff W, Chapman MJ, Van Eck M, Curtiss LK, Burnett JR, Cartland SP, Quinn CM, et al: HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ Res. 116:1133–1142. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Goldstein JL and Brown MS: A century of cholesterol and coronaries: From plaques to genes to statins. Cell. 161:161–172. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Axsom K, Berger JS and Schwartzbard AZ: Statins and diabetes: The good, the bad and the unknown. Curr Atheroscler Rep. 15:2992013. View Article : Google Scholar : PubMed/NCBI

29 

Hennekens CH, Teng B and Pfeffer MA: Statins and diabetes: Current perspectives and implications for clinicians. Am J Med. 130:504–506. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Sattar N and Taskinen MR: Statins are diabetogenic-myth or reality? Atheroscler Suppl. 13:1–10. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Furman BL: Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol. 70:5.47.1–20. 2015. View Article : Google Scholar

32 

Hong C, Marshall SM, McDaniel AL, Graham M, Layne JD, Cai L, Scotti E, Boyadjian R, Kim J, Chamberlain BT, et al: The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice. Cell Metab. 20:910–918. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Attie AD and Seidah NG: Dual regulation of the LDL receptor-some clarity and new questions. Cell Metab. 1:290–292. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Kruit JK, Kremer PH, Dai L, Tang R, Ruddle P, de Haan W, Brunham LR, Verchere CB and Hayden MR: Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice. Diabetologia. 53:1110–1119. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yu Q, Wang F, Meng X, Gong Y, Wang Y, Xu C and Wang S: Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice. Mol Med Rep 18: 2780-2788, 2018.
APA
Yu, Q., Wang, F., Meng, X., Gong, Y., Wang, Y., Xu, C., & Wang, S. (2018). Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice. Molecular Medicine Reports, 18, 2780-2788. https://doi.org/10.3892/mmr.2018.9239
MLA
Yu, Q., Wang, F., Meng, X., Gong, Y., Wang, Y., Xu, C., Wang, S."Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice". Molecular Medicine Reports 18.3 (2018): 2780-2788.
Chicago
Yu, Q., Wang, F., Meng, X., Gong, Y., Wang, Y., Xu, C., Wang, S."Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice". Molecular Medicine Reports 18, no. 3 (2018): 2780-2788. https://doi.org/10.3892/mmr.2018.9239
Copy and paste a formatted citation
x
Spandidos Publications style
Yu Q, Wang F, Meng X, Gong Y, Wang Y, Xu C and Wang S: Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice. Mol Med Rep 18: 2780-2788, 2018.
APA
Yu, Q., Wang, F., Meng, X., Gong, Y., Wang, Y., Xu, C., & Wang, S. (2018). Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice. Molecular Medicine Reports, 18, 2780-2788. https://doi.org/10.3892/mmr.2018.9239
MLA
Yu, Q., Wang, F., Meng, X., Gong, Y., Wang, Y., Xu, C., Wang, S."Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice". Molecular Medicine Reports 18.3 (2018): 2780-2788.
Chicago
Yu, Q., Wang, F., Meng, X., Gong, Y., Wang, Y., Xu, C., Wang, S."Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice". Molecular Medicine Reports 18, no. 3 (2018): 2780-2788. https://doi.org/10.3892/mmr.2018.9239
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team